ArticleBMC complementary medicine and therapies2026
Integrated network pharmacology and bioinformatics analysis reveals MME as key target of Notoginsenoside R1 in diabetic nephropathy.
Xinyu Gan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.